GRP78 Knockdown Enhances Apoptosis via the Down-Regulation of Oxidative Stress and Akt Pathway after Epirubicin Treatment in Colon Cancer DLD-1 Cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GRP78 Knockdown Enhances Apoptosis via the Down-Regulation of Oxidative Stress and Akt Pathway after Epirubicin Treatment in Colon Cancer DLD-1 Cells
Authors
Keywords
Apoptosis, Small interfering RNAs, AKT signaling cascade, Oxidative stress, Colorectal cancer, Cancer treatment, Phosphatases, Antioxidants
Journal
PLoS One
Volume 7, Issue 4, Pages e35123
Publisher
Public Library of Science (PLoS)
Online
2012-04-19
DOI
10.1371/journal.pone.0035123
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
- (2011) Adam Lister et al. Molecular Cancer
- The Role of Nrf2 and Cytoprotection in Regulating Chemotherapy Resistance of Human Leukemia Cells
- (2011) Stuart A. Rushworth et al. Cancers
- Glucose regulated protein 78 (GRP78) is overexpressed in colorectal carcinoma and regulates colorectal carcinoma cell growth and apoptosis
- (2010) Xiaoming Xing et al. ACTA HISTOCHEMICA
- Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathways
- (2010) Lu-Hua Zhang et al. BRAIN RESEARCH
- PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs
- (2010) Marco Falasca CURRENT PHARMACEUTICAL DESIGN
- Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cells
- (2010) Yidan Lin et al. LUNG CANCER
- Glucose-Regulated Protein 78 Is a Novel Contributor to Acquisition of Resistance to Sorafenib in Hepatocellular Carcinoma
- (2009) Jeng-Fong Chiou et al. ANNALS OF SURGICAL ONCOLOGY
- Tangeretin Sensitizes Cisplatin-Resistant Human Ovarian Cancer Cells through Downregulation of Phosphoinositide 3-Kinase/Akt Signaling Pathway
- (2009) E.-S. A. Arafa et al. CANCER RESEARCH
- Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells
- (2009) Hanane Akhdar et al. EUROPEAN JOURNAL OF CANCER
- Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway
- (2009) R Naughton et al. LEUKEMIA
- Nrf2 signaling and cell survival
- (2009) Suryakant K. Niture et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Expression and clinical significance of Glucose Regulated Proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus
- (2008) Rupert Langer et al. BMC CANCER
- Mechanisms of ROS modulated cell survival during carcinogenesis
- (2008) J.S. Clerkin et al. CANCER LETTERS
- Evaluation of epirubicin-induced acute oxidative stress toxicity in rat liver cells and mitochondria, and the prevention of toxicity through quercetin administration
- (2008) M. Kebieche et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Cadmium activates the mitogen-activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5
- (2008) Long Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway
- (2008) Long Chen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission
- (2008) Stefanie Sowinski et al. NATURE CELL BIOLOGY
- Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN
- (2008) S.-K. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started